000963 Stock Overview
Engages in the wholesale and retail of pharmaceutical products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Huadong Medicine Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥35.25 |
| 52 Week High | CN¥39.15 |
| 52 Week Low | CN¥25.96 |
| Beta | 0.64 |
| 1 Month Change | 2.41% |
| 3 Month Change | 0.40% |
| 1 Year Change | 6.62% |
| 3 Year Change | -6.77% |
| 5 Year Change | 82.64% |
| Change since IPO | 803.27% |
Recent News & Updates
Be Wary Of Huadong Medicine (SZSE:000963) And Its Returns On Capital
Feb 12
An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 49% Undervalued
Dec 16We Think Huadong Medicine (SZSE:000963) Can Stay On Top Of Its Debt
Nov 29Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings
Nov 13Recent updates
Be Wary Of Huadong Medicine (SZSE:000963) And Its Returns On Capital
Feb 12An Intrinsic Calculation For Huadong Medicine Co., Ltd (SZSE:000963) Suggests It's 49% Undervalued
Dec 16We Think Huadong Medicine (SZSE:000963) Can Stay On Top Of Its Debt
Nov 29Investors Aren't Buying Huadong Medicine Co., Ltd's (SZSE:000963) Earnings
Nov 13There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital
Sep 23Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price
Aug 05Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly
Jun 28There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital
Jun 10Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Apr 21Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings
Apr 08Is Huadong Medicine (SZSE:000963) A Risky Investment?
Mar 16Shareholder Returns
| 000963 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 2.5% | 1.9% | 2.0% |
| 1Y | 6.6% | -2.1% | 17.2% |
Return vs Industry: 000963 exceeded the CN Healthcare industry which returned -1.7% over the past year.
Return vs Market: 000963 underperformed the CN Market which returned 16.8% over the past year.
Price Volatility
| 000963 volatility | |
|---|---|
| 000963 Average Weekly Movement | 4.3% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 000963 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000963's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 16,969 | Liang Lv | www.eastchinapharm.com |
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment.
Huadong Medicine Co., Ltd Fundamentals Summary
| 000963 fundamental statistics | |
|---|---|
| Market cap | CN¥61.69b |
| Earnings (TTM) | CN¥3.21b |
| Revenue (TTM) | CN¥41.71b |
19.2x
P/E Ratio1.5x
P/S RatioIs 000963 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000963 income statement (TTM) | |
|---|---|
| Revenue | CN¥41.71b |
| Cost of Revenue | CN¥27.99b |
| Gross Profit | CN¥13.72b |
| Other Expenses | CN¥10.51b |
| Earnings | CN¥3.21b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 11, 2025
| Earnings per share (EPS) | 1.84 |
| Gross Margin | 32.89% |
| Net Profit Margin | 7.70% |
| Debt/Equity Ratio | 10.1% |
How did 000963 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield51%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 08:39 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Huadong Medicine Co., Ltd is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changming He | BOCI Research Ltd. |
| Ethan Cui | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |